Back to briefing
Research United States

AI-ACLD Study: Artificial Intelligence in Advanced Chronic Liver Disease

The AI-ACLD Study investigates an AI-based system that records variations in patients with advanced chronic liver disease using data collected from an Apple Watch. It aims to determine whether the system can detect early clinical improvement or deterioration and improve care management and quality of life. The study is conducted in the United States.

Published
23 Jul 2026
2 min read 1 source
Intelligence brief
United States / Research
CH

The AI-ACLD Study investigates an AI-based system that records variations in patients with advanced chronic liver disease using data collected from an Apple Watch. It aims to determine whether the system can detect early clinical improvement or deterioration and improve care management and quality of life. The study is conducted in the United States.

Why it matters

It demonstrates how wearable technology and AI can be applied to chronic disease monitoring, a field of interest for Swiss AI research and healthcare innovation.

Primary source record
ClinicalTrials.gov

Original source record. Open the original record to verify the underlying announcement.

Your privacy choices

Allow optional Google Analytics to help us understand how the site is used. Analytics stays off unless you accept. Privacy details